EICHOR
● Active Not Recruiting
Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia
Condition: Diffuse Large B Cell Lymphoma · Multiple Myeloma · Sponsor: Leuko Labs, Inc.
About this study
Pivotal study to validate the diagnostic performance of PointCheck, the first non invasive device to preliminary detect neutropenia in cancer patients receiving intermediate/high risk antineoplastic therapy.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (6)
| University of Hawaii Cancer Center | Honolulu, Hawaii, United States | — |
| Norton Healthcare Cancer Center | Louisville, Kentucky, United States | — |
| Massachussetts General Hospital | Boston, Massachusetts, United States | — |
| Hackensack University Medical Center | Hackensack, New Jersey, United States | — |
| MDA | Houston, Texas, United States | — |
| Hospital Universitario 12 de Octubre | Madrid, Spain | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06323447